Search

We interviewed Pedro Martínez, Councilor for Economic Promotion at the Salamanca City Council, to learn about the potential of its ecosystem and the opportunities the Green Innovation Forum offers for

Meet Phoenix Biosolutions, our new member. We spoke with Carlos Rodríguez-Villa Förster, CEO.

The Spanish Bioindustry Association (AseBio) has organized a conference at the Ministry of Science that brought together leading institutional, political, and industry stakeholders to present a

TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow. Data presented at AGBT demonstrates TruPath Genome's accuracy in detecting rare genetic disease. Broad

In a context in which most of these pathologies have a genetic origin, tools such as whole genome sequencing (WGS) are set to transform diagnosis and clinical practice, shortening times and improving

Meet ELE Biotech, our new member. We spoke with Laura Vallés Saiz and Elena Calvo Cantero, CEO and co-founder, and COO and also co-founder, respectively.

Globally, fewer than 30% of researchers are women, indicating that female talent is still not fully integrated into research and innovation.

Strong cash position at year-end 2025: $33.3 million (€28.4 million).

The integration of polygenic risk models based on genome-wide association studies (GWAS) enables healthcare professionals to incorporate genetic risk stratification into clinical practice and advance

The second edition of this high-level event will take place on March 24 in Brussels under the motto “Driving Impact: Bio-based innovation for a competitive, sustainable Europe”

The Dutch company continues to promote the deep tech ecosystem in Spain.

Condalab invites you to the second edition of our Digital Cell Biology Conference, a free online event aimed at professionals working in biomedical or veterinary research, where cellular models and

The company is the leading private entity in financing in Extremadura and in Cluster 6 - Food, bioeconomy, natural resources, agriculture, and environment of the European Union's research and

Despite advances in early detection, risk-adapted treatment, and precision oncology, the findings indicate that prostate cancer continues to generate high and increasing costs, particularly in

Meet Molefy Pharma, our new member. We spoke with Alfonso de Egaña, CEO.